INTRODUCTION
Twelve years ago investigators of the Liverpool School of Tropical Medicine (1943) and Lourie and Collier (1943) showed the effectiveness of penicillin in spirochaetosis, and staff members of the United States Public Health Service (Mahoney, Arnold, and Harris, 1943) Five years ago I had the privilege of speaking to the Medical Society for the Study of Venereal Diseases on the treponematoses-syphilis, yaws, and pinta-as a world problem. The doubts about the curative effectiveness of penicillin alone as an antisyphilitic drug were then perhaps only beginning to be dispelled in Britain, while in many other countries medical workers, taking a more traditional attitude, were relying solely on their past experience with metal chemotherapy. To-day the outlook has changed practically everywhere, and penicillin alone has become the drug of choice throughout the world. This is illustrated by an international study undertaken by WHO in 1953 in which some 70 per cent. of 277 leading clinics of dermato-venereology in 55 countries were reported to be using penicillin alone in the treatment of early syphilis (Willcox, Guthe, Idsoe, and Reynolds, 1954) . Furthermore, there is increasing evidence that penicillin is gradually being used as the sole treatment for all forms of the disease, including the latent and late systemic stages. Another noteworthy trend has been the tendency to draw conclusions on the long-term curative value of penicillin in the treponematoses after a much shorter period than would have been possible in the era of metal chemotherapy. According to classical criteria, a patient adequately treated for early syphilis with metals and showing negative blood and cerebrospinal fluid tests after 4 years had every reason to consider himself permanently cured. To-day, an increasing number of investigators are prepared to consider a patient cured after only 2 years' observation. This attitude is undoubtedly based on the fact that most of the true penicillin failures in the treatment of the early infection occur within 6 to 9 months oftreatment and are very seldom observed after 2 years. Furthermore, long-term observations have shown that late involvements of the cardiovascular and nervous systems are apparently very rare indeed after penicillin therapy. From Finally, on the laboratory side the Treponema pallidum immobilization (TPI) technique has become a useful diagnostic tool, and the T. pallidum agglutination (TPA) test is now being similarly developed. It is a paradox that these tests, which are required for much-needed study of the nature of the immunity phenomena, have only become available at a time when the main interest of the clinician is to apply an intensive form of treatment with penicillin, the immediate effect of which is to bring about the destruction of the treponemes regardless of concomitant immunity processes.
St (Weiss and Wright, 1953) and phenyltoloxamine penicillin (Granatek, Gottstein, and Cheney, 1954) . Others have been developed in a search for preparations with repository effect which might obviate the use of procaine or oily components, e.g., benethamine penicillin, which appears to possess properties very similar to procaine penicillin; and penicillin G diethylamino-ethylester hydriodide (" Neopenil "), which has produced cerebrospinal fluid concentrations ten times as high as other penicillins (Schimmel, Wilson, Matteucci, and Flippin, 1952) . The most important development, however, has been the introduction of N,N'-dibenzylethylenediamine dipenicillin G, known as benzathine penicillin G,* first described by Szabo and others (1951) . Studies of its properties have been carried out by Elias, Price, and Merrion (1951) , Lepper, Rodriguez, Blatt, and Spies (1952) , Seifter, Glassman, Begany, Ehrich, and Beckfield (1954) , and others. This procaine-free, slowly absorbed, amino-salt of penicillin G has low toxicity, few side-reactions, and a penicillinaemia of long duration, whether administered orally or intramuscularly. In addition, there is the obvious advantage that the oily vehicle used in the repository PAM preparations can be dispensed with in parenteral benzathine preparations.
Curative Aspects.-A number of reports have been published on the therapeutic use of benzathine penicillin in various infections. These are summarized in Table I Since " the major determinant factor in the therapeutic activity in penicillin is the aggregate time ... for which the drug remains at bactericidal levels" (Eagle, Fleischman, and Musselman, 1950) , it is of primary interest to compare the penicillinaemia obtainable with benzathine penicillin G with that obtainable with PAM. This is illustrated in Fig. 3 (overleaf) , showing the penicillinaemia curves of the two repository preparations following several schedules. Curves are also included for " Panbiotic " or " all-purpose penicillin "-a triple combination of potassium (0 3 mega units), procaine (0 3 mega units), and benzathine penicillin G (0-6 mega units) investigated by Rein, Buckwalter, Mann, Landy, and Flax (1953) , and for benzathine penicillin G in oil with aluminium monostearate (BOM).
These are average values of units of penicillin per ml. serum, as determined by the standard (Grin, Guthe, Payanandha, D'Mello, and Swaroop, 1954) , in pinta (Marquez, quoted by Rein and Mann, 1954) , and in syphilis (Vilanova and Alvarado, 1954 , and the WHO International Co-operative Clinical Group, of which the British Clinical Co-operative Group is a part). Long-term observations have also been made in the U.S.A. by Smith and his co-workers (1954b). Shafer and Smith (1954) compared the results of treatment schedules of 2-4 mega units benzathine penicillin with those of 4-8 mega units PAM in previously untreated secondary syphilis over a period of two years (Fig. 4) The studies undertaken on the preventive use of drugs during the past few decades, particularly those with antimalarials, are well known, as are experiences with sulphonamide products in infections with staphylococci, meningococci, streptococci, gonococci, certain intestinal pathogens, and other micro-organisms. The preventive use of antibiotics in susceptible infections introduced no new principle, but the greater effectiveness, lower toxicity, and fewer complications and side-reactions associated with antibiotic products made possible an extension of the range of preventive medication. Thus, for several years penicillin and other antibiotics have been extensively used in prolonged or intensive courses in surgery, to prevent various infections, ranging from those following bowel resection or bone surgery to the management of surface wounds and burns. The introduction of repository procaine and benzathine penicillin with long-lasting bactericidal blood-levels has further added to the preventive effectiveness of antibiotics. These are also used in ear, nose, and throat infections, and in dentistry where benzathine penicillin is apparently beginning to replace other penicillin salts (Nathanson, Morin, and Mallet 1953) .
Macchiavello, Omar, El Sayed, and Rahman (1954) demonstrated the effectiveness of mass penicillin (PAM) prophylaxis among cerebrospinal meningococcal meningitis contacts and carriers in the Sudan. Pollitzer (1954) has pointed out the impressive preventive effect of streptomycin when given to contacts in endemic plague areas. Lyons (1947) used aureomycin protectively in the mass control of trachoma and acute seasonal conjunctivitis in Egypt and Morocco. In the U.S.A. Seal and others (1953) showed the preventive effect in streptococcal respiratory infections of procaine penicillin and chlortetracycline used over a period of 6 to 8 weeks in a naval population. In the United Kingdom similar epidemiological mass-treatment schemes have been used in the prevention of scarlet fever and sore throat epidemics. In combating the recurrence of rheumatic fever, concern is not with a micro-organism already present in the throat of the individual in whom the disease is in the quiescent state, but with the prevention of Group A streptococcal infection. Monthly intramuscular injections of benzathine penicillin for 1 year were shown by Stollerman and Rusoff (1952) to be completely effective in preventing this infection in children. Karelitz, Chang, and Matthews (1954) showed that procaine penicillin and benzethacil were highly effective in the prevention of bacterial complications of measles. The observations of Stollerman and Rusoff have subsequently been confirmed by a number of other investigators Tidwell, 1954; Perry and Gillespie, 1954; Edstrom, 1954; Breese, 1953; Chamovitz and Catanzaro, 1953) . In elderly patients with bronchial asthma and pulmonary emphysema, benzathine penicillin is of value in preventing respiratory infections due to haemolytic streptococci, pneumococci, and non-resistant staphylococci (Barach, 1953) .
These are selected examples of current preventive uses of penicillin. There are many other fields in which this and other antibiotics are now being used, but where the indications are less clearly defined and where the immediate and long-range effectiveness cannot be readily evaluated. No doubt there is a certain amount of misuse of antibiotics in most countries to-day, both in curing and in preventing infections. Caution in their use should undoubtedly be exercised by the medical profession, and their application should be confined to specific clinical or preventive indications. Finland (1953) has stated that, in the evaluation of the preventive use of chemotherapeutic and antibiotic drugs, serious consideration must be given to:
(a) the price to be paid in side-effects; (b) the best method of accomplishing a set objective; (c) the types of preventive use to which antibiotics should be put.
The preventive use of penicillin may thus be classified under two heads:
(1) Short -duration, for a specific purpose, such as individual prevention (e.g., in ophthalmia neonatorum), or mass prophylaxis (in meningococcus infection); (Kolmer, 1954) , which indicate that, in the prophylaxis and abortion of syphilitic infection, repository PAM is highly effective, and that benzathine penicillin is almost four times more effective than PAM. This demonstrated effectiveness of preventive penicillin treatment does not mean that the use of this or other antibiotics on epidemiological indication is the accepted practice everywhere. There are different views on the subject, not only for venereal syphilis and gonorrhoea but also for the possible risks of syphilitic infection incurred by physicians, dentists, nurses, midwives, and medical technologists in the course of their professional duties. Some of these views have recently been published in this journal (King, 1954; Willcox, 1954) . New problems have arisen, ranging from speculation on the ultimate consequences of possible misuse of antibiotics by the profession to the psychological impact which the preventive use of penicillin might have on the public. On the latter aspect two opposing views are encountered. One is that venereal diseases still strike terror in the hearts of many patients, and that fear and uncertainty about infection are often more catastrophic than infection itself; while the other contends that the ease with which the public now believes that syphilis and gonorrhoea can be prevented and cured with antibiotics has largely removed the fear often associated with these infections in the past. There is a growing tendency for the public to regard these infections as they would any other communicable disease.
Among the problems posed by the use of penicillin on epidemiological indications is that of the financial responsibility of health insurance and social security organizations. Thus, in Germany, the question actually led to an international survey of opinion among venereologists on preventive treatment, with particular reference to married partners, to which McElligott (1953) contributed on the British side. Of the twelve participants nine favoured preventive penicillin treatment-some with certain reservations-while three preferred to treat patients after the development of clinical lesions. One participant favoured preventive treatment if gonorrhoea was expected, but not if syphilis was the hazard.
Other countries have gone further in this question than is perhaps generally recognized; for example, Mexico (Campos Salos, 1952 and the U.S.A. (personal communication, 1955) . In the U.S.A., health directives now prescribe in detail the procedures to be followed. The following quotation is from the Venereal-Disease-Control Manual of Maryland State (1954):
For some time now it has been customary to treat female contacts of gonorrhoea solely on epidemiological grounds. The application of this same principle to alleged sexual contacts of primary and secondary syphilis has been made in several States and in controlled experimental demonstrations. There is no doubt that this procedure materially reduces the number of cases of early syphilis developing in the contact group. Obviously the advantage lies in (a) the avoidance of symptomatic infection among contacts without clinical evidence of infection who are in the incubation period of the disease at the time of their initial examination, and who would either delay reporting for medical care after the development of infectious lesions or would be completely lost from observation, and (b) a considerable saving in the time required of personnel in the follow up of such contacts.
Alleged sexual contacts of primary and secondary syphilis should therefore be treated, following a physical examination and a serological test for syphilis at the time of their initial visit to the clinic. If they are found to have clinical syphilis at that visit they will of course receive the same schedule of treatment as would any other case with the same manifestations. If, on the other hand, they show no evidence of disease they should be given 1-2 million units benzathine penicillin G (or 2-4 mega units PAM) in a single injection ... Although statistical data indicate that the annual incidence of new cases of early syphilis in the U.S.A. as a whole is no higher than that recorded in the Scandinavian countries, penicillin treatment on epidemiological grounds has apparently been accepted as a new weapon in the control of venereal syphilis (and of gonorrhoea). The reason for this is perhaps that small epidemics of venereal syphilis still occur from time to time in the U.S.A. This is shown in Fig. 5 (overleaf) , which depicts an outbreak of obvious clinical syphilis in Georgia in 1953 (Olansky and Price, 1955) .
The relevant observation by the authorities on this remarkable epidemiological episode was as follows:
On this occasion an individual rejected by his draft board was diagnosed as having secondary syphilis. As a result of contact tracing and interviewing, approximately seventy cases of primary and secondary syphilis were detected. In addition, approximately 200 other patients were treated prophylactically because they had been exposed to syphilis, and enough man-power was not available to apply proper follow-up procedures to these people. From the references already made concerning the management of venereal diseases in the U.S.A. it is clear that, in that country, the preventive effect of repository penicillin is relied upon to such an extent that it becomes a supplementary arm in epidemiological work. At the same time emphasis is being placed on the post-treatment observation of contacts who have received preventive treatment. Such contacts should be followed monthly for the first 3 months, quarterly for the remainder of the first year, and annually thereafter.
All cases of gonorrhoea are given 0-6 mega unit benzathine penicillin, since this schedule allows adequate time for tracing and treating the regular sexual contacts of the patient, thereby preventing " ping-pong" infections. Moreover, it represents adequate treatment for the majority of persons who may be incubating syphilis. In the U.S.A. gonorrhoea patients so treated are advised to return 4 months later for a follow-up examination and a serological test for syphilis.
In venereal syphilis, Durel (1954) has advocated the use of benzathine penicillin in prostitutes, with appropriate maintenance doses given every 3 to 4 weeks. This procedure follows a pattern similar to that previously used in Mexico (Campos Salos, 1952 , Burma, and Hong Kong (reports to WHO), where PAM was given weekly. Recently we have had an opportunity of studying in some detail the effect of benzathine penicillin in two female population groups exposed to infection. The results are presented in Table II (opposite).
The two groups were living under identical conditions in a walled-off, " red-light" district of a city, in, let us say, Ruritania. The follow-up percentages by the end of 12 months' observation were 91 and 92 for the test group and the control group, respectively. The cumulative attack rate of early clinical syphilis was 13-6 per cent. in the control group and appeared to be 3.9 per cent. in the test group; this percentage of 3 9 represented one case only-a woman who had missed her previous monthly injection with benzathine penicillin. Sero-positivity in the test group showed a declining tendency, although the difference by the end of the first 12 months was not statistically significant. However, the trend is suggestive of a "curative effect" in latent syphilis by a regime which by some investigators might be compared to the practice of " consolidation" treatment. : All children under 18 yrs, plus members of household with one or more infectious cases.
In two households the treatment of clinical and/or serological cases alone did not prevent perpetuation of the disease through cross-infections or reinfections. Only simultaneous preventive penicillin treatment of household members without overt signs of the disease, but exposed to the risk of infection, eliminated it. These observations were made over a period of 21 years during which time all household members were clinically and serologically examined and re-examined at five different surveys. Similar observations have been made in other programmes.
The mass effect of preventive penicillin treatment in treponematoses campaigns has also been studied in three endemic areas with approximately the same population, in order to compare different treatment policies (Table III) . The basic data and percentage reduction in infections and seropositivity are also shown graphically (Fig. 7) .
Preventive treatment procedures have been used in many treponematoses programmes, e.g., the Gold Coast, India, Liberia, Morocco, Nigeria, the Philippines, Thailand, and elsewhere. From the experience gained in these campaigns it has become clear that preventive treatment at the initial survey will not only suppress most rapidly and economically the foci of infection in the community, but will also Data on the use of benzathine penicillin G on epidemiological indications in the endemic treponematoses are still limited owing to the present unsuitability of preparations for field use. It is nevertheless clear that the longer-lasting treponemicidal blood-and tissue-levels given by this drug will increase the prophylactic value of penicillin in susceptible contacts during mass campaigns; when stable presuspended benzathine penicillin preparations become available there will be more time in the mass programme to suppress active foci from which the infection might again spread in the community. The application of such preparations in the incubation period will increase the likelihood of aborting completely the treponemal infection, while at the same time providing an extended period of protection against re-infection in exposed individuals. In undiagnosed latency in clinical mass campaigns the prolonged penicillinaemia will tend to provide greater protection against relapses.
Although the experimental evidence in animals and man suggests the effectiveness of proportionately smaller dosages of penicillin for preventive purposes-and this, for reasons of economy, is the principle currently followed in mass campaigns against the non-venereal treponematoses-the tendency in venereal syphilis appears to be towards the use of relatively large dosages in preventive treatment. This trend has developed simultaneously with the tendency:
(a) to increase the penicillin dosage in gonorrhoea to ensure that adequate therapy is provided for a syphilitic infection in the incubation period at the time of treatment; (b) to increase the penicillin effect through the use of appropriate dosages of longer-acting preparations such as benzathine penicillin G.
In the foregoing discussion, reference has, in general, been made to the intramuscular use of penicillin, except for a brief reference to the use of oral tablets among naval personnel in ports. Several years ago the WHO Expert Committee on Venereal Infections and Treponematoses warned against the uncertainties and dangers of penicillin tablet medication in gonorrhoea and the treponematoses, and this view now appears to be generally accepted.
Side-effects of Penicillin
Turning now to an appraisal of the side-effects resulting from the use of penicillin in the management of the treponematoses, the Jarisch-Herxheimer reaction in infected individuals and the possible development of penicillin resistance in the treponeme are only mentioned in passing, since the lysis phenomenon is a fairly constant feature with any kind of effective antisyphilitic drug and since resistance has not so far proved of practical importance.
Of the greatest importance, however, is the risk of sensitization of the host, of which many drugs are capable. Untoward reactions might therefore be expected with antibiotics as well. The first fatal penicillin reaction was reported by Waldbott (1949) and others have since been published in England, France, and the U.S.A. (Stroud, 1952; Mayer and others, 1953; Siegal, Steinhardt, and Gerber, 1953) . In an incomplete survey in the U.S.A. in 1953, the Food and Drug Administration found nineteen fatalities among 59 reactors to penicillin over a period of 2 years in 95 major American hospitals, representing 51,000 hospital beds (Welch, Lewis, Kerlan, and Putnam, 1953) . One fatal case was from oral benzathine penicillin G. Since then many studies have been carried out by a number of investigators (O'Brien and Smith, 1952; Nathanson and others, 1953 Lepper and others, 1952; Feinberg, Feinberg, and Moran; Smith and others, 1954b (Jennings and Olansky, 1954) .
It is not likely that the use of one penicillin salt will prevent sensitization reactions after the use of other penicillin salts, at least not for those at present in use, including benzathine penicillin.
Serious side-effects are not more prevalent with benzathine penicillin than with PAM in singlesession treatment schedules in the treponematoses. However, subjective complaints of local discomfort at the site of the injection are sometimes made after benzathine penicillin, but such complaints were not considered an objective criterion of "side-reactions" in the study material from the U.S.A. discussed in Table IV . That the procainefree benzathine penicillin may actually give rise to local pain more frequently than PAM is suggested by observations in Thailand (Grin, 1953) , Morocco, Norway, and Britain (communications to WHO) , although there may be doubts whether this can be considered a contraindication to the use of this preparation if its advantages are otherwise convincing.
On the whole, it may be said that the sensitizing potential of penicillin is remarkably low, and while the incidence of penicillin reactions has probably increased in some countries where the drug has been available for some time and has been widely used, reactions remain relatively infrequent considering the enormous quantity of penicillin consumed annually (estimated world production in 1954, 500 tons). Considerable reservation should be made on the general validity of published observations of the stated frequency of penicillin reactions in small, highly selected population samples, such as groups of hospital patients, etc., for material of this kind tends to over-emphasize the true incidence. In the long run the use of benzathine penicillin represents an advantage over PAM. The use of single-session treatment schedules with benzathine penicillin and the lower dosages which can be effectively administered will tend to limit the degree of sensitization and the number of penicillin reactors. A practical consequence of this has been that in the U.S.A. the manufacture of PAM is now being discontinued in favour of benzathine penicillin.
SUMMARY
No small proportion of the world's penicillin production is used in the management of the treponematoses. The long-acting characteristics of procaine penicillin G in oil with 2 per cent. aluminium monostearate-PAM-have, during the past few years, made it the penicillin preparation of choice, since the major factor in the effectiveness of penicillin is the time for which it maintains a treponemicidal level in the blood. The recent introduction of benzathine penicillin G-which, when given intramuscularly, is absorbed and eliminated about twice as slowly as PAM-therefore represents a considerable advance in the further simplification of the management of treponemal infections.
Clinical trials have shown that the same curative effect can be obtained in early treponemal infections with a single injection procedure using a dosage of benzathine penicillin half that of PAM.
Preventive treatment on epidemiological indications is an established principle in the effective management of the non-venereal, endemic treponematoses. In some countries such procedures have also been introduced in the management of venereal syphilis (and gonorrhoea). The superior preventive effect of benzathine penicillin (as compared with PAM) has been demonstrated in individuals exposed to contagion and in individuals incubating the treponematoses. The sensitizing potential of penicillin is low, but previous experience with the antibiotic, repeated application in prolonged treatment schedules, and possibly the use of large dosages, tends to increase the incidence of reactions. The price to be paid in side-reactions from penicillin is small in relation to its curative and preventive value, particularly when compared to the toxic reactions and mortality resulting from arsenotherapy. The introduction of benzathine penicillin in the management of the treponematoses will further limit the incidence of sensitization reactions, since lower dosages make one-session treatment schedules a practical proposition.
The data available on the place of benzathine penicillin in the management of the treponematoses are still incomplete and more time must elapse before a fuller evaluation of its advantages and disadvantages can be made. However, in some countries, benzathine penicillin G is already replacing PAM in clinical practice in the management of syphilis (and gonorrhoea). It is suggested that when more stable presuspended preparations become available benzathine penicillin might become the preparation of choice in the control of the non-venereal, endemic treponematoses.
